2
Most read
9
Most read
10
Most read
COMPUTER SIMULATION
IN TRO D U C TIO N
A computer simulation or acomputer model is acomputer program that
attempts to simulateanabstract model of aparticular system.
Computer simulation in the fieldof Pharmacokinetic and Pharmacodynamics
or in silica model is need of the hour in the biomedical field.
•Computational resources available today
, large-scale models of the body can
be used to produce realistic simulations.
•It involves the use of computer simulations of biological systems, including
cellular subsystems (such as the networks of metabolites and enzymes which
comprise metabolism, signal transduction, pathways and gene regulatory
networks), to both analyze and visualize the complex connections of these
cellular processes.
The process to create an imitation of real world
system or physical object into acomputer model.
Performing experiments to understand the
behavior of system and evaluating new strategies.
Then observing events, processes, propertiesand
behavior of system, with computer model.
What is Computer Simulation
Process of Simulating a System
Simulation means mimic anycondition and computer
simulation is done by computer model using algorithms
There is mainly 4 level of the simulation of
pharmacokinetics and pharmacodynamics.
Level 1 Computer Simulation of the Whole Organism.
Level 2 Computer Simulation of Isolated Tissues and
Organs.
Level 3 Computer Simulations of the Cell.
Level 4 Computer simulation of Proteins and Genes.
Level 1 computer simulation of whole organism
For the formation of the model simulation of the whole
organism is very important.
The whole organism can be mathematically represented which
mimic the whole physiological condition through the simulation
of the whole organism.
The whole series of the organ can be generated for the clinical
trial purpose.
There are two appraoches for simulation of whole organism
A. PK/PD model
B. PBPK model
A. PK/PD model
•It is used to describe the exposure-response relationship.
•Model is coupled with a model of a diseased state.
•It can be described by Linear model (linear relationship between drug
concentration and response), E max model (non-linear model that assumes a
maximum effect (E max) at a certain drug concentration (EC50-Concentration
producing 50% of the maximum effect of a drug),Sigmoidal E max model (is
a more complex version of the E max model, this model is commonly used to
describe the time course of drug effects in humans)
Purpose
• To estimate therapeutic window
• Dose selection
• Identify mechanism of action
1.In-vitro physiological and in-vivo pharmacokinetics data
are collected to help design PK/PD study protocol.
2.Acute PK/PD pilot model is then conducted to examine
the exposure-response relationship.
3.Set up and screening with the PK/PD model in drug
discovery is a typical and important process that requires
ongoing refinement as new information become available
and the project moves forward.
4.PK/PD model is continuously updated throughout
different drug development to relevant new data.
Steps involved in PK/PD model
The mathematicallymodeling technique for predictingADME of asynthetic or natural
chemicalsubstance inhuman.
Usually multicompartmental model withpredicted organ or tissue withcorrection
corresponding to blood or lymph flow
.
Model madeup of compartment corresponding to the different physiologicalorgan of
thebody linkedbythecirculating blood system.
Eachcompartment exactly describes byatissue volume and blood flowrate thatis
specificto thespeciesof theintestine. Eachtissue is definedwith theassumption of
either perfusion rate limitedor permeabilityrate limited.
PBPK models are constructed using a series of differential equations that are
parameterized with known physiological variables and represent a mathematical
descriptionoftheprocessesthatgoverntheADMEofadrug.Thepatient’scharacteristics
(age, sex, weight, body composition, organ function, genetics, etc.) can also be utilized
and integrated into a PBPK model. The drug properties used in PBPK models include
molecular weight, logP
, pKa, protein binding data, blood/plasma ratio, metabolism,
permeability/solubility,transportmechanism,etc
B. PBPK model
(physiology based pharmacokinetic model)
PBPK model is made up of mainly two parts
1.Anatomical backbone-
It contains a species-specific physiological parameter
that are independent of the drug and hence can be
applied to any compound.
2.The drug-specific part which can consist of individual
drug’s ADME property applied to the relevant process
within each tissue compartment.
PBPK model
Level 2
Computer simulation of isolated tissue and orga
Computer simulation of isolated tissues and organs involves
the use of computer models to simulate the behavior of
tissues and organs in response to drugs.
This approach allows researchers to study the
pharmacokinetics and pharmacodynamics of drugs in a
controlled environment, without the need for animal or
human subjects.
Level 2
Computer simulation of isolated tissue and orga
Heart, kidney
,brain, liver can be asubject of
mathematical modeling research.
Liver simulation is very useful in both field biomedical
and pharmaceutical.
This model offers increased level of detail and
temporal resolution which gives good mixing and
uniformity of hypothesis.
Simulation of heart and liver can be carried out with
distributed blood tissue model that is known as BTEX
model.
Level 3
Computer simulation of cell
•Simulation of the cell is very complicated because of the
need to know about how intracellular and membrane proces
takes place.
•There is no universal record for how the intracellular
and cell wall working take place.
•The virtual cell in an online respiratory of some
of these model makes an available computer
simulation of the whole cell to its user network.
•Another online respiratory of the biophysical model
is at the CellML website.
•It is mainly used in biomedical research.
Level 4
Computer simulation of protein andgenes
In, Computational protein design the most interacting factor is
that it can lead to design and laboratory creation of the
structure that are not present in nature.
The approach tried to identify agene that leads to disease
susceptibility and allow mapping of genetic dataonto network
based on an ordinary differential equation.
Simulation to pharmacotherapy was in the field of HIV/AIDS
treatment, through the development of HIV viral based on the
clinical data that shed considerable light on the disease
mechanism.
One can produce anewer sequence of the gene also help in
translation and transcription process as well as protein
identification.

More Related Content

PPTX
virtual trial FED and fasted state.pptx
PPTX
Computational modeling of drug disposition
PPTX
Barriers to protein and peptide delivery.pptx
PPTX
Computer aided formulation development
DOCX
Computer simulation in pharmacokinetics and pharmacodynamics
PPTX
Descriptive Vs Mechanistic Modeling.pptx
DOCX
4 unit.computer aided notes m.pharmcomputer aided biopharamacutical charecter...
virtual trial FED and fasted state.pptx
Computational modeling of drug disposition
Barriers to protein and peptide delivery.pptx
Computer aided formulation development
Computer simulation in pharmacokinetics and pharmacodynamics
Descriptive Vs Mechanistic Modeling.pptx
4 unit.computer aided notes m.pharmcomputer aided biopharamacutical charecter...

What's hot (20)

PPTX
Pharmacokinetics and pharmacodynamics of biotechnological products
PPTX
correlation of invivo data with invitro dissolution data.pptx
PPTX
Pharmaceutical automation
PDF
Targeted Drug Delivery Systems First Year M. Pharmacy.
PPTX
Computational modeling of drug disposition
PDF
Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...
PPTX
Statistical modeling in Pharmaceutical research and development.pptx
PPTX
GASTROINTESTINAL ABSORPTION SIMULATION CADD.pptx
PPTX
Artificial Intelligence (AI), Robotics and Computational fluid dynamics
PPTX
GI simulation final.pptx
PPTX
computer in market analysis
PPTX
Market analysis
PPTX
Modified drug delivery systems, Targeted drug delivery and biopharmaceutical ...
PPTX
Micro capsules or microspheres
PPTX
COMPUTERS IN PHARMACEUTICAL DEVELOPMENT
PPTX
MPH07 Computers in clinical development.pptx
PPTX
Computational modeling of drug disposition
PPTX
Formulation and evaluation of protein drug delivery system.
PPTX
Computer simulation in pkpd
PPTX
Biopharmaceutics of antisense molecule and aptamers
Pharmacokinetics and pharmacodynamics of biotechnological products
correlation of invivo data with invitro dissolution data.pptx
Pharmaceutical automation
Targeted Drug Delivery Systems First Year M. Pharmacy.
Computational modeling of drug disposition
Gastrointestinal absorption simulation using in silico methodology; by Dr. Bh...
Statistical modeling in Pharmaceutical research and development.pptx
GASTROINTESTINAL ABSORPTION SIMULATION CADD.pptx
Artificial Intelligence (AI), Robotics and Computational fluid dynamics
GI simulation final.pptx
computer in market analysis
Market analysis
Modified drug delivery systems, Targeted drug delivery and biopharmaceutical ...
Micro capsules or microspheres
COMPUTERS IN PHARMACEUTICAL DEVELOPMENT
MPH07 Computers in clinical development.pptx
Computational modeling of drug disposition
Formulation and evaluation of protein drug delivery system.
Computer simulation in pkpd
Biopharmaceutics of antisense molecule and aptamers
Ad

Similar to whole body.pptx (20)

PDF
Computer simulation
PDF
COMPUTER SIMULATIONS IN PHARMACOKINETICS AND PHARMACODYNAMICS
PPTX
computer simulation in pharmacokinetics and pharmacodynamics
PPTX
COMPUTER AIDED DRUG DESIGN.pptx
PPTX
COMPUTER SIMULATIONS IN PHARMACOKINETICS & PHARMACODYNAMICS
PDF
Computer simulations in pharmacokinetics and pharmacodynamics
PPTX
computer simulations.pptx
PDF
Computer Simulation In Gut Absorption, Distribution Of.pdf
PPTX
Moving from animal model to the clinic
PPTX
COMPUTATIONAL MODELING IN DRUG DISPOSITION.pptx
PPTX
Pharmacometrics 2.2.17
PPTX
Pharmacometrics 2.2.17
PDF
PKPD seminar
PDF
Computational (In Silico) Pharmacology.pdf
PPTX
STC411 Computer Simulation Techniques
PPTX
Computational modelling of drug disposition
PDF
Dr. A. Sumathi - M.Pharm - CADD - Question Bank
PPTX
Common Practice Guidelines: A Significant Gap in Computational Modeling and S...
PDF
Pharmacometrics
PPTX
computational modeling of drug disposition
Computer simulation
COMPUTER SIMULATIONS IN PHARMACOKINETICS AND PHARMACODYNAMICS
computer simulation in pharmacokinetics and pharmacodynamics
COMPUTER AIDED DRUG DESIGN.pptx
COMPUTER SIMULATIONS IN PHARMACOKINETICS & PHARMACODYNAMICS
Computer simulations in pharmacokinetics and pharmacodynamics
computer simulations.pptx
Computer Simulation In Gut Absorption, Distribution Of.pdf
Moving from animal model to the clinic
COMPUTATIONAL MODELING IN DRUG DISPOSITION.pptx
Pharmacometrics 2.2.17
Pharmacometrics 2.2.17
PKPD seminar
Computational (In Silico) Pharmacology.pdf
STC411 Computer Simulation Techniques
Computational modelling of drug disposition
Dr. A. Sumathi - M.Pharm - CADD - Question Bank
Common Practice Guidelines: A Significant Gap in Computational Modeling and S...
Pharmacometrics
computational modeling of drug disposition
Ad

More from Dipti Nigam (15)

PPTX
computer aided drug development presentation
PPTX
pharmaceutical applications of Artificial intelligence
PPT
hjgbkjl;k;l';;;mlmk,nkmbnmb jbjjbknkllm;lkm;lk;bbvv
PPTX
emulsion basic principles for pharm D third
PPTX
theory of emulsions, their description, instability
PPTX
Module 1 f (photostability).pptx
PPTX
Module 1 e (theory of disperse system).pptx
PPTX
Module 1 e (theory of disperse system).pptx
PPTX
Module 1a.pptx
PPTX
AI.pptx
PPTX
Quality by Design (Qbd).pptx
PPTX
photostability
PPTX
smedds
PPTX
LVP.pptx
PPTX
DRUG RELEASE KINETICS AND MATHEMATICAL MODELLING.pptx
computer aided drug development presentation
pharmaceutical applications of Artificial intelligence
hjgbkjl;k;l';;;mlmk,nkmbnmb jbjjbknkllm;lkm;lk;bbvv
emulsion basic principles for pharm D third
theory of emulsions, their description, instability
Module 1 f (photostability).pptx
Module 1 e (theory of disperse system).pptx
Module 1 e (theory of disperse system).pptx
Module 1a.pptx
AI.pptx
Quality by Design (Qbd).pptx
photostability
smedds
LVP.pptx
DRUG RELEASE KINETICS AND MATHEMATICAL MODELLING.pptx

Recently uploaded (20)

PPTX
operating_systems_presentations_delhi_nc
PDF
Disorder of Endocrine system (1).pdfyyhyyyy
PPTX
Neurology of Systemic disease all systems
PDF
anganwadi services for the b.sc nursing and GNM
PPTX
Math 2 Quarter 2 Week 1 Matatag Curriculum
PDF
WHAT NURSES SAY_ COMMUNICATION BEHAVIORS ASSOCIATED WITH THE COMP.pdf
PDF
Review of Related Literature & Studies.pdf
PDF
LATAM’s Top EdTech Innovators Transforming Learning in 2025.pdf
PPTX
Neurological complocations of systemic disease
PDF
Kalaari-SaaS-Founder-Playbook-2024-Edition-.pdf
PPSX
namma_kalvi_12th_botany_chapter_9_ppt.ppsx
PPTX
Copy of ARAL Program Primer_071725(1).pptx
PPTX
Diploma pharmaceutics notes..helps diploma students
DOCX
THEORY AND PRACTICE ASSIGNMENT SEMESTER MAY 2025.docx
PPTX
MMW-CHAPTER-1-final.pptx major Elementary Education
PDF
Compact First Student's Book Cambridge Official
PPTX
Cite It Right: A Compact Illustration of APA 7th Edition.pptx
PPTX
4. Diagnosis and treatment planning in RPD.pptx
PPTX
CHROMIUM & Glucose Tolerance Factor.pptx
PPTX
2025 High Blood Pressure Guideline Slide Set.pptx
operating_systems_presentations_delhi_nc
Disorder of Endocrine system (1).pdfyyhyyyy
Neurology of Systemic disease all systems
anganwadi services for the b.sc nursing and GNM
Math 2 Quarter 2 Week 1 Matatag Curriculum
WHAT NURSES SAY_ COMMUNICATION BEHAVIORS ASSOCIATED WITH THE COMP.pdf
Review of Related Literature & Studies.pdf
LATAM’s Top EdTech Innovators Transforming Learning in 2025.pdf
Neurological complocations of systemic disease
Kalaari-SaaS-Founder-Playbook-2024-Edition-.pdf
namma_kalvi_12th_botany_chapter_9_ppt.ppsx
Copy of ARAL Program Primer_071725(1).pptx
Diploma pharmaceutics notes..helps diploma students
THEORY AND PRACTICE ASSIGNMENT SEMESTER MAY 2025.docx
MMW-CHAPTER-1-final.pptx major Elementary Education
Compact First Student's Book Cambridge Official
Cite It Right: A Compact Illustration of APA 7th Edition.pptx
4. Diagnosis and treatment planning in RPD.pptx
CHROMIUM & Glucose Tolerance Factor.pptx
2025 High Blood Pressure Guideline Slide Set.pptx

whole body.pptx

  • 2. IN TRO D U C TIO N A computer simulation or acomputer model is acomputer program that attempts to simulateanabstract model of aparticular system. Computer simulation in the fieldof Pharmacokinetic and Pharmacodynamics or in silica model is need of the hour in the biomedical field. •Computational resources available today , large-scale models of the body can be used to produce realistic simulations. •It involves the use of computer simulations of biological systems, including cellular subsystems (such as the networks of metabolites and enzymes which comprise metabolism, signal transduction, pathways and gene regulatory networks), to both analyze and visualize the complex connections of these cellular processes.
  • 3. The process to create an imitation of real world system or physical object into acomputer model. Performing experiments to understand the behavior of system and evaluating new strategies. Then observing events, processes, propertiesand behavior of system, with computer model. What is Computer Simulation
  • 4. Process of Simulating a System Simulation means mimic anycondition and computer simulation is done by computer model using algorithms There is mainly 4 level of the simulation of pharmacokinetics and pharmacodynamics. Level 1 Computer Simulation of the Whole Organism. Level 2 Computer Simulation of Isolated Tissues and Organs. Level 3 Computer Simulations of the Cell. Level 4 Computer simulation of Proteins and Genes.
  • 5. Level 1 computer simulation of whole organism For the formation of the model simulation of the whole organism is very important. The whole organism can be mathematically represented which mimic the whole physiological condition through the simulation of the whole organism. The whole series of the organ can be generated for the clinical trial purpose. There are two appraoches for simulation of whole organism A. PK/PD model B. PBPK model
  • 6. A. PK/PD model •It is used to describe the exposure-response relationship. •Model is coupled with a model of a diseased state. •It can be described by Linear model (linear relationship between drug concentration and response), E max model (non-linear model that assumes a maximum effect (E max) at a certain drug concentration (EC50-Concentration producing 50% of the maximum effect of a drug),Sigmoidal E max model (is a more complex version of the E max model, this model is commonly used to describe the time course of drug effects in humans) Purpose • To estimate therapeutic window • Dose selection • Identify mechanism of action
  • 7. 1.In-vitro physiological and in-vivo pharmacokinetics data are collected to help design PK/PD study protocol. 2.Acute PK/PD pilot model is then conducted to examine the exposure-response relationship. 3.Set up and screening with the PK/PD model in drug discovery is a typical and important process that requires ongoing refinement as new information become available and the project moves forward. 4.PK/PD model is continuously updated throughout different drug development to relevant new data. Steps involved in PK/PD model
  • 8. The mathematicallymodeling technique for predictingADME of asynthetic or natural chemicalsubstance inhuman. Usually multicompartmental model withpredicted organ or tissue withcorrection corresponding to blood or lymph flow . Model madeup of compartment corresponding to the different physiologicalorgan of thebody linkedbythecirculating blood system. Eachcompartment exactly describes byatissue volume and blood flowrate thatis specificto thespeciesof theintestine. Eachtissue is definedwith theassumption of either perfusion rate limitedor permeabilityrate limited. PBPK models are constructed using a series of differential equations that are parameterized with known physiological variables and represent a mathematical descriptionoftheprocessesthatgoverntheADMEofadrug.Thepatient’scharacteristics (age, sex, weight, body composition, organ function, genetics, etc.) can also be utilized and integrated into a PBPK model. The drug properties used in PBPK models include molecular weight, logP , pKa, protein binding data, blood/plasma ratio, metabolism, permeability/solubility,transportmechanism,etc B. PBPK model (physiology based pharmacokinetic model)
  • 9. PBPK model is made up of mainly two parts 1.Anatomical backbone- It contains a species-specific physiological parameter that are independent of the drug and hence can be applied to any compound. 2.The drug-specific part which can consist of individual drug’s ADME property applied to the relevant process within each tissue compartment.
  • 11. Level 2 Computer simulation of isolated tissue and orga Computer simulation of isolated tissues and organs involves the use of computer models to simulate the behavior of tissues and organs in response to drugs. This approach allows researchers to study the pharmacokinetics and pharmacodynamics of drugs in a controlled environment, without the need for animal or human subjects.
  • 12. Level 2 Computer simulation of isolated tissue and orga Heart, kidney ,brain, liver can be asubject of mathematical modeling research. Liver simulation is very useful in both field biomedical and pharmaceutical. This model offers increased level of detail and temporal resolution which gives good mixing and uniformity of hypothesis. Simulation of heart and liver can be carried out with distributed blood tissue model that is known as BTEX model.
  • 13. Level 3 Computer simulation of cell •Simulation of the cell is very complicated because of the need to know about how intracellular and membrane proces takes place. •There is no universal record for how the intracellular and cell wall working take place. •The virtual cell in an online respiratory of some of these model makes an available computer simulation of the whole cell to its user network. •Another online respiratory of the biophysical model is at the CellML website. •It is mainly used in biomedical research.
  • 14. Level 4 Computer simulation of protein andgenes In, Computational protein design the most interacting factor is that it can lead to design and laboratory creation of the structure that are not present in nature. The approach tried to identify agene that leads to disease susceptibility and allow mapping of genetic dataonto network based on an ordinary differential equation. Simulation to pharmacotherapy was in the field of HIV/AIDS treatment, through the development of HIV viral based on the clinical data that shed considerable light on the disease mechanism. One can produce anewer sequence of the gene also help in translation and transcription process as well as protein identification.